ARCHIVES

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Quality Oncology Wins Pilot Contract For Cancer Management In Fla.

July 27, 2001

Biopsies Could Be Reduced By Computer-Aided-Detection

December 26, 2003

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

UCSD Center Designated Comprehensive; Siteman Center In St. Louis Wins Core Grant.

August 31, 2001